Key Takeaway: The article provides a privacy overview regarding the use of cookies on the MAZE Therapeutics website. It explains the necessity of cookies for website functionality and user experience. Additionally, it mentions the use of Google Analytics for collecting anonymous visitor data to enhance website performance.
Price reaction · baseline $24.27 (2026-06-05 close) · 1 other MAZE headline(s) in the window, move may be shared
day 0 close · peak
-2.8%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+9%
120-day peak, hindsight
Typical move
1.8%
average across 3 past catalysts
Cash runway
~31 mo
Minimal dilution risk
Lead asset
MZE829
Phase 2 · Proteinuric Kidney Disease
Full Press Release Details
• Privacy Overview
• Essential Cookies
• 3rd Party Cookies
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
These cookies are necessary for our website to function and for measurement purposes. Opt-out rights do not apply to these cookies.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Frequently Asked Questions
What cookies does MAZE Therapeutics use?
MAZE Therapeutics uses essential cookies necessary for website functionality.
How does MAZE use Google Analytics?
MAZE uses Google Analytics to collect anonymous visitor data for website improvement.
Can I opt out of cookies on MAZE's website?
Opt-out rights do not apply to essential cookies used by MAZE's website.